Yu, W., Li, P., Zhou, L., Yang, M., Ye, S., Zhu, D., Huang, J., Yao, X., Zhang, Y., Li, L., Zhao, J., Zhu, K., Li, J., Zheng, C., Lan, L., Wan, H., Yao, Y., Zhang, H., Zhou, D., Jin, J., Liang, A. (2025). A phase 1 trial of prizloncabtagene autoleucel, a CD19/CD20 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma. Blood. https://doi.org/10.1182/blood.2024026401